Mojtahedi MF

No ORCID on file · 4 papers in corpus
case-report 2025
Targeted Management of Adenomyosis: Frozen Embryo Transfer Outcomes With GNRH-Agonist and Letrozole Therapy
·doi:10.21203/rs.3.rs-6579011/v1

Abstract Objective: To apply a combined protocol using GnRH agonists and letrozole for endometrial preparation in patients with severe adenomyosis undergoing frozen euploid single embryo transfer (eFET). Design: Case series. Setting: Terti…

observational 2024
Infertility treatments and risk of breast benign diseases: a case‒control study
BMC women's health ·doi:10.1186/s12905-024-03429-w

BACKGROUND: Theoretically, endocrine fluctuations occurring during infertility treatments, including ovulation induction (OI) and assisted reproductive techniques (ART), could be associated with an increased risk of benign breast diseases (…

rct 2020
A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2020.103248

Resveratrol, a naturally synthesized polyphenolic compound found in some fruits, has anti neoplastic, anti-inflammatory, anti-oxidative, and anti-angiogenic properties. Angiogenesis is an important process in endometriosis which provides bl…

rct 2019
Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial
International journal of reproductive biomedicine ·doi:10.18502/ijrm.v17i9.5101

BACKGROUND: Ovarian stimulation (OS) for poor ovarian response (POR) patients is still a major challenge in assisted reproductive techniques. Aromatase inhibitors as co-treatment in antagonist protocol are suggested to these patients, but t…